Back to Results
First PageMeta Content
Alcohols / Euphoriants / Drug rehabilitation / Ethers / Buprenorphine / Drug Addiction Treatment Act / Opioid dependence / Methadone / Naloxone / Chemistry / Organic chemistry / Morphinans


Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators Final Report Submitted to the Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment
Add to Reading List

Document Date: 2008-01-25 15:42:13

Open Document

File Size: 914,36 KB

Share Result on Facebook

Company

JBS International Inc. / /

Country

United States / United Kingdom / /

/

Event

Product Issues / Person Communication and Meetings / Product Recall / /

Facility

Northern New England Poison Control Center / Epidemiology University of Texas / England’s Cambridge University / /

IndustryTerm

separate search / drug monitoring systems / Internet pharmacies / law enforcement / /

MedicalCondition

seizures / apnea / pain / only mild withdrawal symptoms / opiate addiction / severe respiratory depression / withdrawal symptoms / /

MedicalTreatment

pharmacotherapies / pharmacotherapy / /

Organization

International Narcotics Control Board / Cambridge University / Vermont state police / Vermont office of Drug and Alcohol Programs / Northern New England Poison Control Center / Substance Abuse and Mental Health Services Administration Center / FDA / Center for Excellence / Substance Abuse Treatment Division / Drug Enforcement Administration / University of Texas / /

Person

Bonnie B. Wilford / Petit / Pharmacologic Therapies Ray Hylton / Jr. / /

/

Position

general practitioner / Substance Abuse Library Information Specialist / President / Director / Project Officer / Drummer / R.N. / Director 8630 Fenton Street / /

Product

naloxone / Suboxone / Subutex / Buprenex / /

ProvinceOrState

Vermont / /

Technology

pharmacokinetics / /

SocialTag